14-day Premium Trial Subscription Try For FreeTry Free

iShares Nasdaq Biotechnology Index Fund ETF Price (Quote)

$133.28
+0.260 (+0.195%)
At Close: May 07, 2024

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 IBB stock ended at $133.28. This is 0.195% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 0.81% from a day low at $132.47 to a day high of $133.54.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical iShares Nasdaq Biotechnology Index Fund prices

Date Open High Low Close Volume
Feb 26, 2024 $137.87 $139.40 $137.67 $139.16 2 565 343
Feb 23, 2024 $137.37 $138.82 $137.37 $138.19 1 255 910
Feb 22, 2024 $135.53 $137.79 $135.20 $137.17 1 341 996
Feb 21, 2024 $134.84 $135.45 $134.08 $135.26 1 548 885
Feb 20, 2024 $135.19 $136.06 $134.16 $134.87 2 033 191
Feb 16, 2024 $135.93 $136.90 $135.41 $135.73 2 247 435
Feb 15, 2024 $135.10 $136.77 $134.76 $136.52 1 912 059
Feb 14, 2024 $133.36 $134.89 $133.24 $134.80 1 491 508
Feb 13, 2024 $133.11 $133.71 $131.27 $132.30 2 287 870
Feb 12, 2024 $134.93 $135.78 $134.09 $135.76 1 357 405
Feb 09, 2024 $134.34 $134.89 $133.92 $134.59 1 670 824
Feb 08, 2024 $133.73 $134.55 $133.15 $134.25 1 252 117
Feb 07, 2024 $135.67 $135.67 $133.66 $133.72 1 843 839
Feb 06, 2024 $134.71 $136.16 $134.44 $136.14 2 275 982
Feb 05, 2024 $134.04 $135.27 $132.87 $134.85 2 246 923
Feb 02, 2024 $135.22 $135.50 $133.78 $134.60 2 164 828
Feb 01, 2024 $134.63 $136.47 $133.83 $136.25 2 171 898
Jan 31, 2024 $136.37 $136.69 $134.23 $134.38 1 856 283
Jan 30, 2024 $136.88 $137.03 $135.75 $136.58 2 035 800
Jan 29, 2024 $135.35 $137.54 $134.63 $137.49 1 486 032
Jan 26, 2024 $135.88 $136.74 $135.32 $135.35 1 932 625
Jan 25, 2024 $135.49 $136.52 $134.91 $135.69 2 505 901
Jan 24, 2024 $137.01 $137.01 $134.72 $134.80 1 959 335
Jan 23, 2024 $135.84 $136.42 $135.02 $136.36 1 124 736
Jan 22, 2024 $134.57 $136.11 $134.40 $135.62 1 818 602
Click to get the best stock tips daily for free!

About iShares Nasdaq Biotechnology Index Fund

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representin... IBB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT